High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
about
LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYPreventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyCost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in CambodiaSynthetically modified L-histidine-rich peptidomimetics exhibit potent activity against Cryptococcus neoformansSynthesis and Antimicrobial Activities of His(2-aryl)-Arg and Trp-His(2-aryl) Classes of Dipeptidomimetics.Cryptococcal meningitis: A neglected NTD?Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in UgandaTesting but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme.Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa.Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxisUtility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, TanzaniaEfficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.Analyses of pediatric isolates of Cryptococcus neoformans from South Africa.Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.Cryptococcal Meningitis: Diagnosis and Management Update.Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapyCryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyAdjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin AmericaNew Insights into HIV/AIDS-Associated Cryptococcosis.A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.Pattern, Clinical Characteristics, and Outcome of Meningitis among HIV-Infected Adults Admitted in a Tertiary Hospital in North Western Tanzania: A Cross-Sectional Study.When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.Integrating clinical services for HIV, tuberculosis, and cryptococcal disease in the developing world: a step forward with 2 novel diagnostic testsUtility of Cryptococcal Antigen Screening and Evolution of Asymptomatic Cryptococcal Antigenemia among HIV-Infected Women Starting Antiretroviral Therapy in Thailand.Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
P2860
Q26783210-1BB86668-8238-4B0D-8F78-B41259D240E0Q26994750-E2B7E6CD-A42E-41D1-AB4F-EF5D3D2919D6Q28748511-A100FC97-90EE-4753-B9D0-65C54E7D2CD0Q33787558-924FCACA-3AB5-4E06-97F6-C3172A67920DQ33791478-377804B3-E77D-4832-9EB1-C9098ABC54B7Q33852819-2727C62E-E656-43CB-AB0A-02D1934E970CQ33855961-FEFDF018-6927-406A-B189-B1D083110AD5Q33858110-5CCC6CC6-52D7-408D-90EB-C10CD70024B0Q33888707-6072E26F-D47C-4E39-B467-B9FAA80FAC94Q33892987-D223552C-6058-4265-A502-0A360281DABEQ34024241-0738E8E6-1459-4279-9CB6-A26C574FF867Q34415736-80433838-2807-470D-B5E8-A8E36D6139E4Q34487479-3016ACF9-E233-46E9-8104-99D5845E72CDQ34516367-24E28549-813C-4BD8-A31C-9913E18A06CFQ35097032-7EB508F5-A49F-459A-9ADD-1D4FE98522EDQ35396977-FB6F69D8-05CA-4F03-9513-52F3ADC57C5CQ35923885-CEE4D28A-6EDC-4306-B9A4-2F9A7ED3DA0FQ35951094-5B129B13-03FF-4E94-82C2-05F8E0E7CE44Q36366992-4EAA9362-8214-47AD-B6AF-F0EF9C154398Q36543833-3D2B18C9-8B18-4404-9D33-B91792B8688AQ36806209-FAFF1EA2-FA5D-4EF1-B7FA-D3F642AF8717Q37105884-1A62C17C-22FD-4548-8BA1-6AA962054B83Q37156556-E9F5420B-AE2C-47E3-8817-C69AFBB60419Q37182083-A5E2280A-3368-41AE-9FB6-490A7CB0CA26Q37215923-AA3DE219-33FA-4CAA-92DC-7CEE198DCE8CQ37249976-FE25CAA1-4E36-469F-976E-837327960C9CQ38021725-C9389FE9-5228-4F44-9D50-3F8BD8183145Q38052948-6F84AE19-3847-4C7F-8D64-7301F60F1A82Q38851467-A7F57531-21A8-42DE-AE55-2A622B35D638Q39379643-091CE456-49C2-4BBF-A4E3-64A8119CFFA0Q40538476-F770A2E9-7776-41AD-B51D-03527C0C5068Q41585583-84DB63FF-F548-46D9-A289-8BA7B2FF1E83Q42248892-6E04B9DC-017C-4E0B-8B20-A9987CA8CEF3Q55396875-7DD4CE73-BA25-45D2-A88D-0ECE1F2CA168
P2860
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@ast
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@en
type
label
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@ast
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@en
prefLabel
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@ast
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@en
P2093
P2860
P50
P1433
P1476
High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out
@en
P2093
Angela Loyse
Anthony Williams
Kevin Rebe
Tihana Bicanic
P2860
P304
P356
10.1097/QAD.0B013E32832BE0FC
P407
P577
2009-06-01T00:00:00Z